| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |